Resveratrol prevents streptozotocin-induced diabetes by inhibiting the apoptosis of pancreatic β-cell and the cleavage of poly(ADP-ribose) polymerase

Endocrine Journal

Volumn 59, Issue 2, 2012, Pages 103-109

  Ku, Cheol Ryong ^a   Lee, Hyeon Jeong ^a   Kim, Suk Kyoung ^a   Lee, Eun Young ^a   Lee, Mi Kyung ^b   Lee, Eun Jig ^a,c  

^a Yonsei University College of Medicine   (South Korea)

^b National Health Insurance Corporation   (South Korea)

^c NORTHWESTERN UNIVERSITY   (United States)

Author keywords

Pancreatic cell; Poly(ADP ribose) polymerase; Resveratrol; Streptozotocin

Indexed keywords

CASPASE 3; NICOTINAMIDE; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE; PHYTOALEXIN; POLY(ADENOSINE DIPHOSPHATE RIBOSE); POLYPHENOL; RESVERATROL; STREPTOZOCIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CELL PROTECTION; CONTROLLED STUDY; ENZYME ACTIVATION; ENZYME INHIBITION; GLUCOSE BLOOD LEVEL; GLUCOSE TOLERANCE TEST; MALE; NONHUMAN; PANCREAS ISLET BETA CELL; PROTEIN CLEAVAGE; RAT; SPRAGUE DAWLEY RAT; STREPTOZOCIN DIABETES;

ANIMALS; ANTIOXIDANTS; APOPTOSIS; BLOOD GLUCOSE; CASPASE 3; DIABETES MELLITUS, TYPE 1; ENZYME ACTIVATION; GLUCOSE TOLERANCE TEST; HYPERGLYCEMIA; HYPOGLYCEMIC AGENTS; IN SITU NICK-END LABELING; INSULIN-SECRETING CELLS; MALE; POLY(ADP-RIBOSE) POLYMERASES; PROTEOLYSIS; RATS; RATS, SPRAGUE-DAWLEY; STILBENES; STREPTOZOCIN; TIME FACTORS;

EID: 84863243411     PISSN: 09188959     EISSN: 13484540     Source Type: Journal    
DOI: 10.1507/endocrj.EJ11-0194     Document Type: Article

References (20)

1. Burkart V, Wang ZQ, Radons J, Heller B, Herceg Z, Stingl L, Wagner EF, Kolb H (1999) Mice lacking the poly(ADP-ribose) polymerase gene are resistant to pancreatic beta-cell destruction and diabetes development induced by streptozocin. Nat Med 5: 314-319.
2. Szab C (2005) Roles of poly(ADP-ribose) polymerase activation in the pathogenesis of diabetes mellitus and its complications. Pharmacol Res 52: 60-71.
3. Kim MJ, Ryu GR, Chung JS, Sim SS, Min DS, Rhie DJ, Yoon SH, Hahn SJ, Kim MS, Jo YH (2003) Protective effects of epicatechin against the toxic effects of streptozotocin on rat pancreatic islets: in vivo and in vitro. Pancreas 26: 292-299.
4. Iritani N, Sugimoto T, Fukuda H, Komiya M, Ikeda H (1997) Dietary soybean protein increases insulin receptor gene expression in Wistar fatty rats when dietary polyunsaturated fatty acid level is low. J Nutr 127: 1077-1083.
5. Lavigne C, Marette A, Jacques H (2000) Cod and soy proteins compared with casein improve glucose tolerance and insulin sensitivity in rats. Am J Physiol Endocrinol Metab 278: E491-500.
6. Baur JA, Sinclair DA (2006) Therapeutic potential of resveratrol: the in vivo evidence. Nat Rev Drug Discov 5: 493-506.
7. Valenzano DR, Cellerino A (2006) Resveratrol and the pharmacology of aging: a new vertebrate model to validate an old molecule. Cell Cycle 5: 1027-1032.
8. Bradamante S, Barenghi L, Villa A (2004) Cardiovascular protective effects of resveratrol. Cardiovasc Drug Rev 22: 169-188.
9. Sinha K, Chaudhary G, Gupta YK (2002) Protective effect of resveratrol against oxidative stress in middle cerebral artery occlusion model of stroke in rats. Life Sci 71: 655-665.
10. Jang M, Cai L, Udeani GO, Slowing KV, Thomas CF, Beecher CW, Fong HH, Farnsworth NR, Kinghorn AD, Mehta RG, Moon RC, Pezzuto JM (1997) Cancer chemopreventive activity of resveratrol, a natural product derived from grapes. Science 275: 218-220.
11. Su HC, Hung LM, Chen JK (2006) Resveratrol, a red wine antioxidant, possesses an insulin-like effect in streptozotocin-induced diabetic rats. Am J Physiol Endocrinol Metab 290: E1339-1346.
12. Sutton R, Peters M, McShane P, Gray DW, Morris PJ (1986) Isolation of rat pancreatic islets by ductal injection of collagenase. Transplantation 42: 689-691.
13. Masutani M, Suzuki H, Kamada N, Watanabe M, Ueda O, Nozaki T, Jishage K, Watanabe T, Sugimoto T, Nakagama H, Ochiya T, Sugimura T (1999) Poly(ADPribose) polymerase gene disruption conferred mice resistant to streptozotocin-induced diabetes. Proc Natl Acad Sci U S A 96: 2301-2304.
14. Thulesen J, Orskov C, Holst JJ, Poulsen SS (1997) Short-term insulin treatment prevents the diabetogenic action of streptozotocin in rats. Endocrinology 138: 62-68.
15. Woon EC, Threadgill MD (2005) Poly(ADP-ribose) polymerase inhibition - where now? Curr Med Chem 12: 2373-2392.
16. Avalos JL, Bever KM, Wolberger C (2005) Mechanism of sirtuin inhibition by nicotinamide: altering the NAD(+) cosubstrate specificity of a Sir2 enzyme. Mol Cell 17: 855-868.
17. Jackson MD, Denu JM (2002) Structural identification of 2'- and 3'-O-acetyl-ADP-ribose as novel metabolites derived from the Sir2 family of beta -NAD+dependent histone/protein deacetylases. J Biol Chem 277: 18535-18544.
18. Wada R, Yagihashi S (2004) Nitric oxide generation and poly(ADP ribose) polymerase activation precede betacell death in rats with a single high-dose injection of streptozotocin. Virchows Arch 444: 375-382.
19. Alkhalaf M, El-Mowafy A, Renno W, Rachid O, Ali A, Al-Attyiah R (2008) Resveratrol-induced apoptosis in human breast cancer cells is mediated primarily through the caspase-3-dependent pathway. Arch Med Res 39: 162-168.
20. Shakibaei M, Csaki C, Nebrich S, Mobasheri A (2008) Resveratrol suppresses interleukin-1beta-induced inflammatory signaling and apoptosis in human articular chondrocytes: potential for use as a novel nutraceutical for the treatment of osteoarthritis. Biochem Pharmacol 76: 1426-1439.